The Role of Serum Coagulation Factors in the Differential Diagnosis of Patients with Pneumonia and Parapneumonic Effusion

1. Arslan S., Ugurlu S, Bulut G. Akkurt I. The association between plasma D-dimmer levels and community-acquired pneumonia. Clinics 2010; 65(6): 593–7.10.1590/S1807-59322010000600006289855020613935Search in Google Scholar

2. Milbrandt EB, Reade MC, Lee M, et al. Prevalence and Significance of Coagulation Abnormalities in Community-Acquired Pneumonia. Molec Med 2009; 15(11–12): 438–445.10.2119/molmed.2009.00091274320519753144Search in Google Scholar

3. Querol-Ribelles JM, Tenias JM, Grau E, et al. Plasma D-dimer levels correlate with outcomes in patients with community-acquired pneumonia Chest, 2004; 126(4): 1087–1092.Search in Google Scholar

4. Freyburger G, Trillaund H, Labrouche S, Gauther P, Javorschi S, Bernard P, et al D dimmer strategy in thrombosis exclusion- a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD metods compared. Thromb Haemost 1998; 79: 32–7.10.1055/s-0037-1614214Search in Google Scholar

5. Levi M, Keller TT, Van Gorp E, Ten Cate H. Infection and inflammation and the coagulation system Cardiovasc. Res. 60(2003) 26–39.Search in Google Scholar

6. Yende S, D’Angelo G, Mayr F, et al. Elevated Hemostasis Markers after Pneumonia Increases One-Year Risk of All-Cause and Cardiovascular Deaths. Bozza PT, ed. PLoS ONE. 2011; 6(8): e22847.10.1371/journal.pone.0022847315426021853050Search in Google Scholar

7. Light RW Parapneumonic effusions and empyema Proc Am Thorac Soc. 2006; 3(1): 75–80.10.1513/pats.200510-113JH16493154Search in Google Scholar

8. Chapman SJ, Davies RJO The management of pleural space infection. Respitology 2004; 9: 4–11.Search in Google Scholar

9. Light RW. Pleural diseases, 4th ed Baltimore: Lippincott, Williams and Wilkins; 2001.Search in Google Scholar

10. Medford AR, Maskell N. Pleural effusion. Postgrad Med J 2005; 81: 702e10.10.1136/pgmj.2005.035352174339716272233Search in Google Scholar

11. Costa Vaz MA, Vargas FS, Marinho FCA, D’Amico EA, Rocha TRF, Teixeira LR. Does the evaluation of coagulation factors contribute to etiological diagnosis of pleural effusions?. Clinics. 2009; 64(9): 891–5.10.1590/S1807-59322009000900010Search in Google Scholar

12. Kabrhel C, Courtney DM, Camargo CA, et al. Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Academic emergency medicine: 2010; 17(6): 589–597.10.1111/j.1553-2712.2010.00765.x353803120624138Search in Google Scholar

13. Nguyen HB, Loomba M, Yang JJ, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. Journal of Inflammation. 2010; 7: 6.10.1186/1476-9255-7-6283700020181046Search in Google Scholar

14. Barthwal M.S. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status. Indian journal of chest diseases and allied sciences 50.3 (2008): 277.Search in Google Scholar

15. Satoshi G, Toshiaki I., Yutaka I, et al A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria Critical Care Medicine: 2006; 34(3): 625–631.Search in Google Scholar

16. Kale S, Yende S, Kong L, et all The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia. PLoS One. 2010; 5(11): e 13852.10.1371/journal.pone.0013852297397621085465Search in Google Scholar

17. Lee MH, Nahm CH, Choi JW. Thrombin-antithrombin III complex, proinflammatory cytokines, and fibrinolytic indices for assessing the severity of inflamemation in pleural effusions. Ann Clin Lab Sci. 2010 Fall; 40(4): 342–7.Search in Google Scholar

18. Chalmers JD, Singanayagam A, Murray MP, et all. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009 Jul; 64(7): 592–7.10.1136/thx.2008.10508019131449Search in Google Scholar

19. El-Habashy M, Elmahalawy I.I, Sonobol A. Value of D-dimer and alkaline phosphatase in the diagnosis of pleural effusion Egyptian Journal of Chest diseases and tuberculosis 2014; 63: 869–872.Search in Google Scholar

20. Dikensoy O., Stathopoulos G.T., Zhu Z, Light R.W. D-dimmer levels in leural effusion Respiratory Medicine 2006; 100: 1337–1341.Search in Google Scholar

21. Seligman R, Ramos-Lima LF, do Amaral Oliveira V, Sanvicente C, Pacheco EF, Rosa KD. Biomarkers in community-acquired pneumonia: A state-of-the-art review. Clinics. 2012; 67(11): 1321–1325.10.6061/clinics/2012(11)17Search in Google Scholar

22. Christ-Crain M, Opal SM Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care. 2010; 14(1): 203.10.1186/cc8155Search in Google Scholar

23. Rohacek M, Szucs-Farkas Z., Pfortmüller C.A. et all Acute Cardiac Disorder or Pneumonia and Concomitant Presence of Pulmonary Embolism. PLoS One. 2012; 7(10): e7418.10.1371/journal.pone.0047418Search in Google Scholar

24. Woodhouse PR, Khnaw K T, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovasucalre disease. Lancet; 1994:19; 343: 435–439.10.1016/S0140-6736(94)92689-1Search in Google Scholar

25. Serhan CN, Chiang N, Van Duke TE Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immnol 2008; 8: 349–361.10.1038/nri2294274459318437155Search in Google Scholar

26. Kasal J, Jovanovic Z, Clermont G, Weissfeld LA, Kaplan V, et al. Comparison of Cox and Gray’s survival models in severe sepsis. Crit Care Med; 2004: 32: 700–707.10.1097/01.CCM.0000114819.37569.4BSearch in Google Scholar